Cargando…
E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation
BACKGROUND: E2F1 is the gatekeeper of the cell cycle controlling an analogous balance between proliferation and cell death. E2F1 expression is elevated in advanced prostate cancer. However, it is still unclear that the roles and mechanisms of E2F1 on prostate cancers. METHODS: Targeted knockdown by...
Autores principales: | Ren, Zijia, Kang, Wenyao, Wang, Lihua, Sun, Baoliang, Ma, Jiajia, Zheng, Chaogu, Sun, Jie, Tian, Zhigang, Yang, Xiaoyi, Xiao, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004456/ https://www.ncbi.nlm.nih.gov/pubmed/24742333 http://dx.doi.org/10.1186/1476-4598-13-84 |
Ejemplares similares
-
Association between NF-κB Pathway Gene Variants and sICAM1 Levels in Taiwanese
por: Wu, Semon, et al.
Publicado: (2017) -
VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway
por: Zhang, Meiying, et al.
Publicado: (2022) -
STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
por: Li, Rui, et al.
Publicado: (2017) -
Involvement of the Akt/NF-κB Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs
por: Yu, Haitao, et al.
Publicado: (2014) -
Infection of human intestinal epithelial cells by invasive bacteria activates NF-κB and increases ICAM-1 expression through NOD1
por: Shin, Woon Geon, et al.
Publicado: (2018)